Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Meibao Life Technology is a prominent Chinese biotechnology company and a key subsidiary of MEBO International, dedicated to the field of regenerative medicine. Founded on the Human Body Regenerative Restoration Science (HBRRS) developed by Dr. Rongxiang Xu, the company focuses on activating the body's innate regenerative potential to repair damaged tissues and organs. Its core product line includes the widely recognized Moist Exposed Burn Ointment (MEBO) and various gastrointestinal regenerative therapies. The company's approach emphasizes in situ regeneration, utilizing specialized nutrient compositions to transform somatic cells into regenerative stem cells. Shanghai Meibao continues to expand its portfolio into nutritional supplements, skincare, and advanced wound care solutions globally. The company maintains a significant presence in both clinical and consumer health markets, leveraging decades of research in tissue repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Meibao Life Technology.